Pharmacokinetic determinants of carbapenem therapy in neonates and children.
Blumer
J L
JL
Department of Pediatrics, Rainbow Babies and Childrens Hospital, Cleveland, OH 44106-6010, USA.
D019540:Area Under Curve; D015780:Carbapenems / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006090:Gram-Negative Bacteria / Q000187:drug effects; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D015378:Imipenem / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D013845:Thienamycins / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D015780:Carbapenems; D013845:Thienamycins; D015378:Imipenem; D000077731:Meropenem